Verapamil Effect in Cystic Fibrosis-related Dysglycemia
Verapamil Effect in Cystic Fibrosis-related Dysglycemia
Not yet recruiting · NCT07688070 · Registry updated 2026-07-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Verapamil Effect in Cystic Fibrosis-related Dysglycemia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Not yet recruiting | Phase 2 | 2026-07-09 | NCT07688070 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rhode Island Hospital | 60 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Diabetes Research Center, Massachusetts General Hospital | Boston | United States | 1 |
| Rhode Island Hospital | Providence | United States | 229 |